Lacosamide for children with paroxysmal kinesigenic dyskinesia
Sign Up to like & getrecommendations! Published in 2020 at "Brain and Development"
DOI: 10.1016/j.braindev.2020.04.009
Abstract: OBJECTIVES This study was performed to evaluate the efficacy and tolerability of lacosamide (LCM) for paroxysmal kinesigenic dyskinesia (PKD) in children. METHODS We retrospectively reviewed the medical charts of pediatric PKD patients (aged read more here.
Keywords: paroxysmal kinesigenic; family history; three children; kinesigenic dyskinesia ... See more keywords